Phillips-Medisize Corporation: Phillips Medisize to buy inhaled drug delivery device maker Vectura from Philip Morris

Phillips Medisize parent company Molex announced that it agreed to acquire Vectura from a subsidiary of cigarette maker Philip Morris. Vectura designs and develops devices and formulations for inhaled drug delivery. Philip Morris paid $1.2 billion for the UK-based company in 2021 as part of its "Beyond Nicotine" effort to phase out cigarettes and develop [...]The post Phillips Medisize to buy inhaled drug delivery device maker Vectura from Philip Morris appeared first on Drug Delivery Business.